This compound is the sodium salt form of a chiral atorvastatin intermediate, featuring a pyrrole core with multiple aromatic rings and hydroxyl groups. It is primarily significant as a pharmaceutical intermediate used in the manufacturing of atorvastatin.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 131275-93-9
Difluoro Atorvastatin Calcium Salt
active pharmaceutical ingredient
Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide
active pharmaceutical ingredient
Isopropyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate
pharmaceutical intermediate
(2E,4E,6E,8E)-3-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-7-methyl-2,4,6,8-nonatetraenoic Acid
acitretin impurity
Carbamic acid, N-[2,2-dimethyl-5-[2-(4-octylphenyl)ethenyl]-1,3-dioxan-5-yl]-, phenylmethyl ester
pharmaceutical intermediate
Tert-Butoxycarbonyl-L-leucine
Peptide synthesis intermediate
Atorvastatine
active pharmaceutical ingredient
Atorvastatine calcique
active pharmaceutical ingredient
sodium (3R,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate
VVRPOCPLIUDBSA-MFHXMFJOSA-M
CC(C)C1=C(C(=C(N1CC[C@@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Na+]